Top 7 Veterinary Prescription Respiratory Medications for Dogs in Canada — 2026 Guide

Flovent HFA is positioned as the best-in-class inhaled corticosteroid for canine respiratory inflammation because its fluticasone formulation provides potent local anti-inflammatory control with lower systemic exposure than oral steroids, making it preferable for long-term management of chronic bronchitis or allergic airway disease. Compared with systemic options like Temaril-P, Flovent reduces systemic side effects and, when used with a spacer such as the AeroDawg, can be more cost-effective over time by reducing rescue medication needs and clinic visits.

Ventolin HFA (salbutamol/albuterol) is the market-leading short-acting beta-agonist for rapid bronchodilation in dogs, valued for its quick onset of action during acute bronchospasm. Technically it complements anti-inflammatory agents like Flovent and is generally less expensive and more widely available than some anticholinergics (Atrovent), making it the go-to rescue agent for owners and clinicians seeking immediate relief.

Atrovent HFA (ipratropium bromide) holds a niche leadership position for dogs where cholinergic bronchoconstriction or intolerance to beta-agonists is a concern, offering bronchodilation via an anticholinergic mechanism that can be additive to beta-agonists. While often costlier than generic short-acting beta-agonists, Atrovent provides a favorable systemic side-effect profile compared with oral bronchodilators and can reduce the frequency of dosing when used in combination protocols.

Theo-Dur extended-release theophylline is a proven oral option for chronic management of canine obstructive airway disease when inhaled therapy is impractical or poorly tolerated, offering sustained bronchodilation and convenience of pill dosing. Its main trade-offs are a narrow therapeutic window and the need for blood-level monitoring, but financially it can be attractive for owners who prefer oral therapy and wish to avoid the upfront cost of spacer devices and repeated nebulization sessions.

Temaril-P (trimeprazine with prednisolone) is a veterinary-specific combination product valued for rapid suppression of cough with concurrent antihistaminic and systemic corticosteroid effects, making it a strong choice for acute allergic or inflammatory respiratory presentations in dogs. Compared to inhaled steroids like Flovent, Temaril-P delivers broader systemic immunosuppression and sedative benefits useful for short-term control, but its systemic nature usually makes it a less desirable long-term financial and safety choice.

AeroDawg is the veterinary-optimized aerosol chamber and mask designed specifically to translate human inhalers (Flovent, Ventolin, Atrovent) into effective canine therapy by improving drug deposition and reducing waste; its technical advantages include canine-specific mask fit, one-way valve design, and simplified owner use. From a cost perspective, the AeroDawg is an economical investment that frequently lowers total medication consumption and clinic visits versus nebulizers or poorly delivered inhaler therapy.